Researchers have just revealed that a protein called MCL1, already known to help cancer cells avoid death, also orchestrates ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...

For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

Aston Sci. Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapeutic cancer vaccines, announced ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

During a median follow-up of 9.0 years (IQR, 6.6-10.9), IBTR occurred in 320 patients (3.6%). The initial model, based on variables from Sanghani et al, achieved a Harrell's C-index of 0.74.

The connection between diet and brain health extends beyond cognitive function to include serious concerns about tumor development and progression. While brain tumors have complex causes involving ...

The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors. Although this type of tumor is usually not life-threatening, the ...

Doctors may soon have a new tool in the fight against one of the most aggressive and lethal forms of cancer—in the form of an 'early warning' signature of precancerous cells. This is the promise of a ...